Tuesday, 22 January 2019
Latest news
Main » Analysts Expect Envision Healthcare (EVHC) Will Post Quarterly Sales of $2.10 Billion

Analysts Expect Envision Healthcare (EVHC) Will Post Quarterly Sales of $2.10 Billion

13 June 2018

They expect $0.80 earnings per share, up 1.27 % or $0.01 from last year's $0.79 per share.

If you own shares of Envision Healthcare stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.

Envision Healthcare (NYSE:EVHC) last announced its quarterly earnings data on Monday, May 7th. Finally, Alps Advisors Inc. purchased a new stake in Envision Healthcare in the fourth quarter worth about $235,000.

Analysts await Envision Healthcare Corporation (NYSE:EVHC) to report earnings on August, 6. The firm scooped it for $2.4 billion a year ago and merged it with its helicopter ambulance service.

Several research firms have recently issued reports on EVHC. The company has a quick ratio of 2.25, a current ratio of 2.27 and a debt-to-equity ratio of 0.65.

Envision Healthcare inked a deal to be bought by KKR & Co. Envision Healthcare had a return on equity of 8.05% and a net margin of 6.06%. Robert W. Baird maintained Envision Healthcare Corporation (NYSE:EVHC) on Wednesday, March 7 with "Buy" rating. Rampart Investment Management Company LLC increased its position in shares of Envision Healthcare by 124.4% during the first quarter.

William Blair has chose to issue a report indicating that Envision Healthcare (NYSE:EVHC) shares are now a "Hold" in analysts report issued to clients on Monday morning. One analyst has rated the stock with a sell rating, two have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of "Buy" and a consensus price target of $68.33. Finally, ValuEngine lowered shares of Envision Healthcare from a "hold" rating to a "sell" rating in a research report on Monday, April 2nd. SG Americas Securities LLC now owns 22,455 shares of the company's stock worth $776,000 after buying an additional 17,286 shares during the last quarter. The company has a market cap of $5.29 billion, a price-to-earnings ratio of 18.00, a price-to-earnings-growth ratio of 0.99 and a beta of 0.46. However, with the company undergoing a challenging period, it may be a relatively good result for investors who towards the start of November 2017 owned shares in the company which were valued at $24 by the stock market.

Under the deal, KKR will acquire Envision for $46 per share, representing a 5 percent premium over Envision's closing price of $43.64 on June 8, according to The Wall Street Journal. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.

Analysts Expect Envision Healthcare (EVHC) Will Post Quarterly Sales of $2.10 Billion